Ledger.Open graph →

SEC Form D · filed January 19, 2016

PharmaCyte Biotech, Inc

Offering

$3.1M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SILVER SPRING, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Thomas W. Liquard · Silver Spring, MDDirector Kenneth L. Waggoner · Silver Spring, MDExec · Director Gerald W. Crabtree · Silver Spring, MDExec · Director Gerald W. Crabtree · Silver Spring, MDExec · Director Thomas W. Liquard · Silver Spring, MDDirector Kenneth L. Waggoner · Silver Spring, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗